LONDON – (AP) Shares in AstraZeneca PLC jumped almost 5 percent Wednesday after the drug maker won a key patent battle in the United States over Seroquel, its anti-psychotic drug and second-best seller.
The decision by a U.S. court to award a summary judgment in AstraZeneca's favor avoids the need for a full . . . .